Zürcher Nachrichten - US abortion ruling threatens access to arthritis drug

EUR -
AED 4.242869
AFN 76.250342
ALL 93.247528
AMD 421.964016
AOA 1060.572233
ARS 1728.626236
AUD 1.637747
AWG 2.082442
AZN 1.95442
BAM 1.95517
BBD 2.323451
BDT 142.793982
BHD 0.43505
BIF 3442.245991
BMD 1.155308
BND 1.479204
BOB 14.010485
BRL 5.937698
BSD 1.153603
BTN 109.671657
BWP 15.643552
BYN 3.4119
BYR 22644.030618
BZD 2.320142
CAD 1.618476
CDF 2612.150446
CHF 0.931709
CLF 0.026743
CLP 1055.974029
CNY 7.798053
CNH 7.795213
COP 3676.986215
CRC 523.120097
CUC 1.155308
CUP 30.615654
CVE 110.229477
CZK 24.187288
DJF 205.419355
DKK 7.475378
DOP 67.276572
DZD 153.581966
EGP 57.556847
ERN 17.329615
ETB 186.190862
FJD 2.553806
FKP 0.858651
GBP 0.857925
GEL 3.021126
GGP 0.858651
GHS 13.525641
GIP 0.858651
GMD 84.914239
GNF 10132.383874
GTQ 8.799164
GYD 241.32223
HKD 9.061864
HNL 30.919233
HRK 7.533413
HTG 150.826824
HUF 362.202869
IDR 20696.181862
ILS 3.470255
IMP 0.858651
INR 109.822567
IQD 1511.219527
IRR 1588317.004451
ISK 141.80247
JEP 0.858651
JMD 183.31537
JOD 0.819133
JPY 182.194907
KES 149.462068
KGS 101.031383
KHR 4675.351658
KMF 493.31666
KRW 1638.053175
KWD 0.357244
KYD 0.961394
KZT 541.347885
LAK 26077.708924
LBP 103304.008718
LKR 387.05831
LRD 208.222897
LSL 18.925383
LTL 3.411323
LVL 0.698834
LYD 7.342475
MAD 10.751835
MDL 20.043627
MGA 4910.290079
MKD 61.505179
MMK 2425.340128
MNT 4157.025473
MOP 9.319937
MRU 46.258492
MUR 54.264829
MVR 17.849421
MWK 2000.294776
MXN 19.917441
MYR 4.722435
MZN 73.836264
NAD 18.925383
NGN 1572.905055
NIO 42.454848
NOK 11.010256
NPR 175.469896
NZD 1.961395
OMR 0.444221
PAB 1.153628
PEN 3.905142
PGK 5.172176
PHP 70.03013
PKR 320.314956
PLN 4.300516
PYG 6879.634064
QAR 4.217541
RON 5.244867
RSD 117.359633
RUB 93.554303
RWF 1694.602551
SAR 4.335326
SBD 9.321425
SCR 15.49527
SDG 693.766315
SEK 10.9609
SGD 1.47936
SLE 28.429167
SOS 659.267569
SRD 43.518143
STD 23912.536514
STN 24.491365
SVC 10.093791
SZL 18.909415
THB 38.2141
TJS 10.647669
TMT 4.043577
TND 3.384909
TRY 54.983998
TTD 7.824327
TWD 37.250007
TZS 3061.563041
UAH 51.622323
UGX 4302.613418
USD 1.155308
UYU 46.385052
UZS 13713.580591
VES 871.346053
VND 30308.341798
VUV 138.133218
WST 3.161791
XAF 655.725817
XAG 0.018555
XAU 0.00027
XCD 3.122277
XCG 2.079039
XDR 0.815516
XOF 655.731491
XPF 119.331742
YER 273.663498
ZAR 18.861902
ZMK 10399.156062
ZMW 22.021903
ZWL 372.008603
  • CMSC

    -0.0600

    21.73

    -0.28%

  • CMSD

    0.0200

    22.04

    +0.09%

  • NGG

    -0.1600

    80.26

    -0.2%

  • BTI

    0.1500

    59.27

    +0.25%

  • RBGPF

    0.0000

    69.74

    0%

  • BCE

    0.0600

    22.06

    +0.27%

  • RIO

    2.5000

    101.51

    +2.46%

  • AZN

    5.8800

    161.5

    +3.64%

  • RELX

    -0.1900

    36.61

    -0.52%

  • GSK

    -0.0700

    51.46

    -0.14%

  • RYCEF

    0.6000

    21

    +2.86%

  • BCC

    -1.6900

    84.8

    -1.99%

  • JRI

    -0.0500

    12.67

    -0.39%

  • VOD

    -0.3800

    15.31

    -2.48%

  • BP

    -1.2300

    41.21

    -2.98%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: Andy Buchanan - POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

Y.Keller--NZN